Epidemiology of intracranial meningioma

Neurosurgery

Volumn 57, Issue 6, 2005, Pages 1088-1094

  Claus, Elizabeth B ^a,b   Bondy, Melissa L ^c   Schildkraut, Joellen M ^d   Wiemels, Joseph L ^e   Wrensch, Margaret ^e   Black, Peter M ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brain tumor; Epidemiology; Meningioma; Neurosurgery; Risk factors; Tumor

Indexed keywords

ANDROGEN; ESTROGEN; HORMONE; HORMONE RECEPTOR; MIFEPRISTONE; PROGESTERONE;

ALLERGY; BENIGN TUMOR; BIOLOGY; BREAST CANCER; CHRONIC PATIENT; DISEASE ASSOCIATION; FAMILY HISTORY; HEAD INJURY; HEREDITY; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; INTRACRANIAL TUMOR; IONIZING RADIATION; LAW; MENINGIOMA; MOBILE PHONE; MORBIDITY; MORTALITY; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION EXPOSURE; REVIEW; RISK ASSESSMENT; RISK FACTOR;

BRAIN NEOPLASMS; HUMANS; INCIDENCE; LEGISLATION; MENINGIOMA; REGISTRIES; UNITED STATES;

EID: 29244452629     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000188281.91351.B9     Document Type: Review

References (78)

1. Antinheimo J, Sankila R, Carpen O, Pukkala E, Sainio M, Jääskeläinen J: Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology 54:71-76, 2000.
2. Black PM: Meningiomas. Neurosurgery 32:643-657, 1993.
3. Black PM, Carroll R, Zhang J: The molecular biology of hormone and growth factor receptors in meningiomas. Acta Neurochir Suppl 65:50-53, 1996.
4. Blitshteyn S, Crook J, Jaeckle KA: Is there an association between meningioma and hormone replacement therapy? A study of women at the Mayo Clinic Jacksonville. From the Society for Neuro-Oncology Meetings Abstracts 2004.
5. Bondy M, Ligon BL: Epidemiology and etiology of intracranial meningiomas: A review. J Neuro-oncol 23:197-205, 1996.
6. Bondy ML, Kryitsis AP, Gu J, de Andrade M, Cunningham J, Levin VA, Bruner JM, Wei Q: Mutagen sensitivity and risk of gliomas: A case-control study. Cancer Res 56:1484-1486, 1996.
7. Bondy ML, Wang LE, El-Zein R, de Andrade M, Selvin MS, Bruner JM, Levin VA, Yung WK, Adatto P, Wei Q: Gamma-radiation, sensitivity and risk of glioma. J Natl Cancer Inst 93:1553-1557, 2001.
8. Brenner AV, Linet MS, Fine HA, Shapiro WR, Selker RG, Black PM, Inskip PD: History of allergies and autoimmune diseases and risk of brain tumor in adults. Int J Cancer 99:252-259, 2002.
9. Busch D: Genetic susceptibility to radiation and chemotherapy injury: Diagnosis and management. Int J Rad Oncol Biol Phys 30:997-1002, 1994.
10. Caggana M, Kilgallen J, Conroy J, Wiencke J, Kelsey K, Miike R, Wrensch M: Associations between ERCC2 polymorphisms and gliomas. Cancer Epidemiol Biomarkers Prev 10:355-360, 2001.
11. Carroll RS, Zhang J, Black PM: Expression of estrogen receptors alpha and beta in human meningiomas. J Neuro-oncol 42:109-116, 1999.
12. Central Brain Tumor Registry of the United States (CBTRUS) web site. Available at: http://www.cbtrus.org/2002/2002products.htm). Accessed October 31, 2004.
13. Chan RC, Thompson GB: Morbidity, mortality, and quality of life following surgery for intracranial meningioma. A retrospective study of 257 cases. J Neurosurg 60:52-60, 1984.
14. Chen J, Chen G: Expression of androgen receptor in meningiomas. J Tongji Med Univ 21:140-142, 2002.
15. Chen P, Wiencke J, Aldape K, Diaz A, Miike R, Kelsey K, Lee M, Liu J, Wrensch M: Association of an ERCC1 polymorphism with adult onset glioma. Cancer epidemiology, biomarkers, and prevention. Cancer Epidemiol Biomarkers Prev 9:843-847, 2000.
16. Chen Z, Zhang J, Mohr G: Enhancing alkylating agent resistance through ERCC2 gene transtection in human glioma cell line. Chin Med J (Engl) 116:1171-1174, 2003.
17. Custer BS, Koepsell TD, Mueller BA: The association between breast carcinoma and meningioma in women. Cancer 94:1626-1635, 2002.
18. Davis FG, Kupelian V, Freels S, McCarthy B, Surawicz T: Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups. Neuro-oncol 3:152-158, 2001.
19. Denmark-Wahnefried W, Schildkraut JM, Thompson D, Lesko SM, McIntyre L, Schwingl P, Paulson DF, Robertson CN, Anderson EE, Walther PJ: Early onset baldness and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 9:325-328, 2000.
20. De Jesus O, Sekhar LN, Parikh HK, Wright DC, Wagner DP: Long-term follow-up of patients with meningiomas involving the cavernous sinus: recurrence progression, and quality of life. Neurosurgery 39:915-919, 1996.
21. De Roos AJ, Rothman N, Inskip PD, Linet MS, Shapiro WR, Selker RG, Fine HA, Black PMcL, Pittman GS, Bell DA: Genetic polymorphisms in GSTM1,-P1,-T1, and CYP2E1 and the risk of adult brain tumors. Cancer Epidemiol Biomarkers Prev 12:14-22, 2003.
22. Donnell MS, Meyer GA, Donegan WL: Estrogen-receptor protein in intracranial meningioma. J Neurosurg 50:499-502, 1979.
23. Dreyer NA, Loughlin JE, Rothman KJ: Cause-specific mortality in cellular telephone users. JAMA 282:1814-1181, 1999.
24. Elexpuru-Camiruaga J, Buxton N, Kandula V, Dias PS, Campbell D, McIntosh J, Broome J, Jones P, Inskip P, Alldersea J, Fryer AA, Strange RC: Susceptibility to astrocytoma and meningioma: Influence of allelism at glutathione S-transferase (GSTT1 and GSTM1) and cytochrome P-450 (CYP2D6) loci. Cancer Res 55:4237-4239, 1995.
25. Evans DG, Huson SM, Donnai D, Neary W, Blair V, Teare D, Newton V, Strachan T, Ramsden R, Harris R: A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet 29:841-846, 1992.
26. Fathallah-Shaykh HM, He B, Zhao LJ, Engelhard HH, Cerullo L, Lichtor T, Byrne R, Munoz L, Von Roenn K, Rosseau G, Glick R, Sherman C, Farooq K: Genomic expression discovery predicts pathways and opposing functions behind phenotypes. J Biol Chem 26:23830-23833, 2003.
27. Goodwin JW, Crowley J, Eyre HJ, Stafford B, Jaeckle KA, Townsend JJ: A phase II evaluation of tamoxifen in unresectable or refractory meningioma: A Southwest Oncology Group study. J Neuro-oncol 15:75-77, 1993.
28. Hardell L, Nasman A, Pahlson A, Hallquist A, Hansson Mild K: Use of cellular telephones and the risk for brain tumors: A case/control study. Int J Oncol 15:113-116, 1999.
29. Harrison MJ, Wolfe DE, Lau TS, Mitnick RJ, Sachdev VP: Radiation-induced meningiomas: Experience at the Mount Sinai Hospital and review of the literature. J Neurosurg 75:564-574, 1991.
30. Hemminki K, Li X, Collins VP: Parental cancer as a risk factor for brain tumors. Cancer Causes Control 12:195-199, 2001.
31. Hittelman WN, Sen P: Heterogeneity in chromosome damage and repair rates after bleomycin in ataxia telangiectasia cells. Cancer Res 48:276-279, 1988.
32. Hsu DW, Efird LT, Hedley-Whyte ET: Progesterone and estrogen receptors in meningiomas: Prognostic considerations. J Neurosurg 86:113-120, 1997.
33. Hsu TC, Johnston DA, Cherry LM, Ramkissoon D, Schantz SP, Jessup JM, Winn RJ, Shirley L, Furlong C: Sensitivity to genotoxic effects of bleomycin in humans: Possible relationship to environmental carcinogenesis. Int J Cancer 43:403-409, 1989.
34. Inskip PD, Mellemkjaer L, Gridley G, Olsen JH: Incidence of intracranial tumors following hospitalization for head injuries (Denmark). Cancer Causes Control 9:109-116, 1998.
35. Inskip PD, Tarone RE, Hatch E, Wilcosky TC, Shaprio WR, Silker RG, Fine HA, Black PMcL, Loeffler JS, Linet M: Cellular-telephone use and brain minors. N Engl J Med 344:79-86, 2001.
36. Jhawar BS, Colditz G, Fuchs C, Stampfer M: Sex steroid hormone exposures and risk for meningiomas. J Neurosurg 99:848-853, 2003.
37. Johansen C, Boice J Jr, McLaughlin J, Olsen J: Cellular telephones and cancer: A nationwide cohort study in Denmark. J Natl Cancer Inst 93:203-207, 2001.
38. Jukich PJ, McCarthy BJ, Surawicz TS, Freels S, Davis FG: Trends in incidence of primary brain tumors in the United States, 1985-1994. Neuro-oncol 3:141-151, 2001.
39. Kalkanis SN, Quinones-Hinojosa A, Buzney E, Ribaudo HJ, Black PM: Quality of life following surgery for intracranial meningiomas at Brigham and Women's Hospital: A study of 164 patients using a modification of the functional assessment of cancer therapy-brain questionnaire. J Neuro-oncol 48:233-241, 2000.
40. Kirsch M, Zhu JJ, Black P: Analysis of the BRCA1 and BRCA2 genes in sporadic meningioma. Genes Chromosomes Cancer 20:53-59, 1997.
41. Kondziolka D, Levy EI, Niranjan A, Flickinger JC, Lunsford LD: Long-term outcomes after meningioma radiosurgery: Physician and patient perspectives. J Neurosurg 91:44-50, 1999.
42. Lambe M, Coogan P, Baron J: Reproductive factors and the risk of brain tumors: A population-based study in Sweden. Int J Cancer 72:389-393, 1997.
43. Lee E, Grutsch J, Persky V, Glick R, Davis F: A case-control study of hormonal factors and meningiomas. From the Society for Neuro-Oncology Meetings Abstracts, 2004.
44. Longstreth WT, Dennis LK, McGuire VM, Drangsholt MT, Koepsell TD: Epidemiology of intracranial meningioma. Cancer 72:639-648, 1993.
45. Longstreth WT Jr, Phillips LE, Drangsholt MT, Koepsell TD, Custer BS, Gehrels JA, van Belle G: Dental x-rays and the risk of intracranial meningioma: A population-based case-control study. Cancer 100:1026-1034, 2004.
46. Lohn S: Mobile phone use and risk of intracranial tumors. Karolinska Institute, Stockholm, Sweden, 2004.
47. Mack EE, Wilson CB: Meningiomas induced by high-dose irradiation. J Neurosurg 79:28-31, 1993.
48. Maxwell M, Galanopoulos T, Neville-Golden J, Antoniades HN: Expression of androgen and progesterone receptors in primary human meningiomas. J Neurosurg 78:456-462, 1993.
49. McCarthy BJ, Davis FG, Freels S, Surawicz TS, Damek DM, Grutsch J, Menck HR, Laws ER Jr: Factors associated with survival in patients with meningioma. J Neurosurg 88:831-839, 1998.
50. Mukherjee S, Tamayo P, Rogers S, Rifkin R, Engle A, Campbell C, Golub TR, Mesirov JP: Estimating dataset size requirements for classifying DNA microarray data. J Comput Biol 10:119-142, 2003.
51. Muscat JE, Malkin MG, Thompson S, Shore R, Stellman S, McRee D, Neugut AI, Wynder EL: Handheld cellular telephone use and the risk of brain cancer. JAMA 284:3001-3007, 2000.
52. Nutt CL, Mani DR, Betensky RA, Tamayo P, Cairncross JG, Ladd C, Pohl U, Hartmann C, McLaughlin ME, Batchelor TT, Black PM, von Deimling A, Pomeroy SL, Golub TR, Louis DN: Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res 63:1602-1607, 2003.
53. Olson JJ, Beck DW, Schlechte JA, Loh PM: Effect of the antiprogesterone RLM:86 on meningioma implanted into nude mice. J Neurosurg 66:584-587, 1987.
54. Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME, Kim JY, Goumnerova LC, Black PM, Lau C, Allen JC, Zagzag D, Olson JM, Curran T, Wetmore C, Biegel JA, Poggio T, Mukherjee S, Rifkin R, Califano A, Stolovitzky G, Louis DN, Mesirov JP, Lander ES, Golub TR: Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415:436-442, 2002.
55. Preston-Martin S: Descriptive epidemiology of primary tumors of the brain, cranial nerves, and cranial meninges in Los Angeles County. Neuroepidemiology 8:283-295, 1989.
56. Preston-Martin S, Henderson BE, Bernstein L: Medical and dental x-rays as risk factors for recently diagnosed tumors of the head. Natl Cancer Inst Monogr 69:175-179, 1985.
57. Preston-Martin S, Mack W, Henderson BE: Risk factors for gliomas and meningiomas in males in Los Angeles County. Cancer Res 49:6137-6143, 1989.
58. Preston-Martin S, Paganini-Hill A, Henderson BE, Pike MC, Wood C: Case-control study of intracranial meningiomas in women in Los Angeles County, California. J Natl Cancer Inst 65:67-73, 1980.
59. Preston-Martin S, Staples M, Farrugia H, Giles G: Primary tumors of the brain, cranial nerves and cranial meninges in Victoria, Australia, 1982-1990: Patterns of incidence and survival. Neuroepidemiology 12:270-279, 1993.
60. Preston-Martin S, Yu MC, Henderson BE, Roberts C: Risk factors for meningiomas in males in Los Angeles Comity. J Natl Cancer Inst 70:863-866, 1983.
61. Preston DL, Ron E, Yonehara S, Kobuke T, Fujii H, Kishikawa M, Tokunaga M, Tokuoka S, Mabuchi K: Tumors of the nervous system and pituitary gland associated with atomic bomb radiation exposure. J Natl Cancer Inst 94:1555-1563, 2002.
62. Rodvall Y, Ahlbom A, Pershagen G, Nylander M, Spannare B: Dental radiography after age 25 years, amalgam fillings and tumors of the central nervous system. Oral Oncol 34:265-269, 1998.
63. Ron E, Modan B, Boice JD Jr, Alfandary E, Stovall M, Chetrit A, Katz L: Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 319:1033-1039, 1988.
64. Rothman KJ, Loughlin JE, Fuch DP, Dreyer NA: Overall mortality of cellular telephone customers. Epidemiology 7:303-305, 1996.
65. Ryan P, Lee MW, North B, McMichael AJ: Amalgam fillings, diagnostic dental x-rays and tumors of the brain, and meninges. Eur J Cancer B Oral Oncol 28B:91-95, 1992.
66. Sachsenheimer W, Bimmler T: Assessment of quality of survival in patients with surgically treated meningioma. Neurochirurgia 35:133-136, 1992.
67. Sadetzki S, Flint-Richter P, Starinsky S, Novikov I, Lerman Y, Goldman B, Friedman E: Genotyping of patients with sporatic and radiation-associated meningiomas. Cancer Epidemiol Biomarkers Prev 14:969-976, 2005.
68. Sankila R, Kaillio M, Jääskeläinen J, Hakulinen T: Long-term survival of 1986 patients with intracranial meningioma diagnosed from 1953 to 1984 in Finland. Comparison of the observed and expected survival rates in a population-based series. Cancer 70:1568-1576, 1992.
69. Schlehofer B, Blettner M, Becker N, Martinsohn C, Wahrendorf J: Medical risk factors and the development of brain tumors. Cancer 69:2541-2547, 1992.
70. Schlehofer B, Blettner M, Preston-Martin S, Niehoff D, Wahrendorf J, Arslan A, Ahlbom A, Choi WN, Giles GG, Howe GR, Little J, Menegoz F, Ryan P: Role of medical history in brain tumor development: Results from the International Adult Brain Tumor Study. Int J Cancer 82:155-160, 1999.
71. Schlehofer B, Blettner M, Wahrendorf J: Association between brain tumors and menopausal status. J Natl Cancer Inst 84:1346-1349, 1992.
72. Shintani T, Hayakawa N, Hoshi M, Sumida M, Kurisu K, Oki S: High incidence of meningioma among Hiroshima atomic bomb survivors. J Rad Res 40:49-57, 1999.
73. Surawicz TS, McCarthy BJ, Kupelian V, Jukich PJ, Bruner JM, Davis FG: Descriptive epidemiology of primary brain and CNS tumors: Results from the Central Brain Tumor Registry of the United States, 1990-1994. Neuro-oncol 1:14-25, 1999.
74. Trizna Z, de Andrade M, Kyritsis AP, Briggs K, Levin VA, Bruner JM, Wei Q, Bondy ML: Genetic polymorphisms in glutathione-s-transferase mu and theta, n-acetyltransferase, and CYP1A1 and risk of gliomas. Cancer Epidemiol Biomarkers Prev 7:553-555, 1998.
75. Watson MA, Gutmann DH, Peterson K, Chicoine MR, Kleinschmidt-DeMasters BK, Brown HG, Perry A: Molecular characterization of human meningiomas by gene expression profiling using high-density oligonucleotide microarrays. Am J Path 161:665-672, 2002.
76. Wei Q, Spitz MR, Gu J, Cheng L, Xu X, Strom SS, Kripke ML, Hsu TC: DNA repair capacity correlates with mutagen sensitivity in lymphoblastoid cell lines. Cancer Epidemiol Biomarkers Prev 5:199-204, 1996.
77. Wrensch M, Minn Y, Chew T, Bondy M, Berger M: Epidemiology of primary brain tumors: Current concepts and review of the literature. Neuro-oncol 4:278-299, 2002.
78. Zhang H, Yu CY: Tree-based analysis of microarray data for classifying breast cancer. Frontiers Biosci 7:c63-c67, 2002.